Inari Medical, Inc.

NasdaqGS NARI

Inari Medical, Inc. Receivables for the quarter ending September 30, 2024: USD 84.40 M

Inari Medical, Inc. Receivables is USD 84.40 M for the quarter ending September 30, 2024, a 21.28% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Inari Medical, Inc. Receivables for the quarter ending September 30, 2023 was USD 69.59 M, a 28.74% change year over year.
  • Inari Medical, Inc. Receivables for the quarter ending September 30, 2022 was USD 54.06 M, a 38.91% change year over year.
  • Inari Medical, Inc. Receivables for the quarter ending September 30, 2021 was USD 38.92 M.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
SV Wall Street
NasdaqGS: NARI

Inari Medical, Inc.

Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Similar companies

LEGN

Legend Biotech Corporation

USD 35.38

-2.02%

PGNY

Progyny, Inc.

USD 21.92

0.41%

StockViz Staff

February 8, 2025

Any question? Send us an email